ArticleInternational journal of clinical oncology2021

On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma.

Kimiharu Takamatsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.